Your browser doesn't support javascript.
loading
Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine.
Kontandreopoulou, Christina-Nefeli; Diamantopoulos, Panagiotis T; Giannopoulos, Andreas; Symeonidis, Argiris; Kotsianidis, Ioannis; Pappa, Vasiliki; Galanopoulos, Athanasios; Panayiotidis, Panayiotis; Dimou, Maria; Solomou, Elena; Loupis, Theodoros; Zoi, Katerina; Giannakopoulou, Nefeli; Dryllis, Georgios; Hatzidavid, Sevastianos; Viniou, Nora-Athina.
Affiliation
  • Kontandreopoulou CN; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Diamantopoulos PT; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Giannopoulos A; Haematology Research Lab, Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation, Athens, Greece.
  • Symeonidis A; Department of Internal Medicine, University Hospital of Patras, Rio, Greece.
  • Kotsianidis I; Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
  • Pappa V; Haematology Division, Second Department of Internal Medicine, Attikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Galanopoulos A; Department of Clinical Hematology, 'G. Gennimatas' District General Hospital, Athens, Greece.
  • Panayiotidis P; First Department of Propedeutic Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Dimou M; First Department of Propedeutic Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Solomou E; Department of Internal Medicine, University Hospital of Patras, Rio, Greece.
  • Loupis T; Haematology Research Lab, Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation, Athens, Greece.
  • Zoi K; Haematology Research Lab, Clinical, Experimental Surgery and Translational Research Center, Biomedical Research Foundation, Athens, Greece.
  • Giannakopoulou N; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Dryllis G; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Hatzidavid S; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Viniou NA; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Leuk Lymphoma ; 63(3): 729-737, 2022 03.
Article de En | MEDLINE | ID: mdl-34738857
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ribonucleotide reductases / Syndromes myélodysplasiques Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Leuk Lymphoma Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Grèce
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ribonucleotide reductases / Syndromes myélodysplasiques Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Leuk Lymphoma Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Grèce